NASDAQ:SLGL

Sol-Gel Technologies Q2 2026 Earnings Results & Report

Sol-Gel Technologies logo
$52.83 -2.13 (-3.88%)
Closing price 04:00 PM Eastern
Extended Trading
$52.56 -0.27 (-0.51%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Sol-Gel Technologies beat analyst expectations on both earnings and revenue in its Q2 2026 results, released August 21, 2026. The company reported EPS of -$1.13 versus the -$2.36 consensus estimate, while revenue of $591 thousand topped the $75 thousand estimate by $516 thousand.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
Before Market Opens
Conference Call Date
Conference Call
12:30 PM ET

Sol-Gel Technologies EPS Results

Actual EPS
-$1.13
Consensus EPS
-$2.36
Beat/Miss
Beat by +$1.23
One Year Ago EPS
N/A
EPS Beat Rate
5 of last 8 quarters

Sol-Gel Technologies Revenue Results

Actual Revenue
$591 thousand
Expected Revenue
$75 thousand
Beat/Miss
Beat by +$516.00 thousand
YoY Revenue Growth
N/A

Earnings Documents

Sol-Gel Technologies Q2 2026 Earnings FAQ

Sol-Gel Technologies (NASDAQ:SLGL) reported earnings of -$1.13 per share for Q2 2026, beating the consensus estimate of -$2.36. The report was announced on Friday, August 21, 2026.

Sol-Gel Technologies reported revenue of $591 thousand for Q2 2026, against a consensus estimate of $75 thousand.

Sol-Gel Technologies Earnings Headlines

Contrasting Sol-Gel Technologies (SLGL) & Its Rivals
Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.tc pixel
Sol-Gel Technologies (SLGL) Projected to Release Earnings on Thursday
See More Sol-Gel Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sol-Gel Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sol-Gel Technologies and other key companies, straight to your email.

About Sol-Gel Technologies

Sol-Gel Technologies (NASDAQ:SLGL) is an Israel-based dermatology company that develops topical treatments for skin conditions. Its proprietary technology uses silica-based microencapsulation to formulate active ingredients for topical use.

The company’s products include Epsolay, a benzoyl peroxide cream approved in the United States for inflammatory lesions of rosacea, and Twyneo, a topical combination of tretinoin and benzoyl peroxide approved for acne vulgaris.

Sol-Gel has pursued commercialization and licensing opportunities in the United States and other markets. Its business also includes developing additional dermatology treatments using its formulation platform.

View Sol-Gel Technologies Profile